0000884731-16-000019.txt : 20160322
0000884731-16-000019.hdr.sgml : 20160322
20160322160122
ACCESSION NUMBER: 0000884731-16-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160319
FILED AS OF DATE: 20160322
DATE AS OF CHANGE: 20160322
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haluska Frank
CENTRAL INDEX KEY: 0001494892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36172
FILM NUMBER: 161521141
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_145867686599262.xml
FORM 4
X0306
4
2016-03-19
0
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001494892
Haluska Frank
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
0
1
0
0
SVP, Clinical R&D, CMO
Common Stock
2016-03-19
4
M
0
6500
0
A
150586
D
Common Stock
2016-03-21
4
S
0
3575
6.4661
D
147011
D
Restricted Stock Units
2016-03-19
4
M
0
6500
0
D
Common Stock
6500.0
0
D
Shares were acquired upon the vesting of a Restricted Stock Unit dated 03/19/2013
Represents shares sold to satisfy withholding tax requirements pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.27 to $6.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer,or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents a right to receive one share of ARIAD common stock.
Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
/s/Edward M. Fitzgerald, Attorney-in-Fact
2016-03-22